These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 20023488)

  • 1. From the bedside back to the bench: the role of preclinical studies in understanding clinical therapies.
    Marshall JC
    Crit Care Med; 2010 Jan; 38(1):329-30. PubMed ID: 20023488
    [No Abstract]   [Full Text] [Related]  

  • 2. Administration of human protein C improves survival in an experimental model of sepsis.
    Messaris E; Betrosian AP; Memos N; Chatzigianni E; Boutsikou M; Economou V; Dontas I; Theodossiades G; Konstadoulakis MM; Douzinas EE
    Crit Care Med; 2010 Jan; 38(1):209-16. PubMed ID: 19726977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of drotrecogin alpha and meropenem treatment on the levels of cytokines in rats with sepsis.
    Dogan N; Boy S; Yildirim A
    Saudi Med J; 2008 Oct; 29(10):1517-9. PubMed ID: 18946589
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of ethyl pyruvate on physical and immunological barriers of the small intestine in a rat model of sepsis.
    Zhang Y; Li M; Meng M; Qin C
    J Trauma; 2009 May; 66(5):1355-64. PubMed ID: 19430239
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comment on: "The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia" by Spiel et al.
    Messaris E; Memos N; Frantzeskaki F; Economou V; Betrosian A
    Thromb Haemost; 2006 Jun; 95(6):1048-9. PubMed ID: 16732392
    [No Abstract]   [Full Text] [Related]  

  • 6. The promise of protein C.
    Griffin JH; Fernández JA; Mosnier LO; Liu D; Cheng T; Guo H; Zlokovic BV
    Blood Cells Mol Dis; 2006; 36(2):211-6. PubMed ID: 16464623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R; Melbostad H; Loomis W; Tobar M; Hoyt DB
    J Trauma; 2005 Sep; 59(3):575-82. PubMed ID: 16361898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-glucan attenuates inflammatory cytokine release and prevents acute lung injury in an experimental model of sepsis.
    Bedirli A; Kerem M; Pasaoglu H; Akyurek N; Tezcaner T; Elbeg S; Memis L; Sakrak O
    Shock; 2007 Apr; 27(4):397-401. PubMed ID: 17414422
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline severity of sepsis in subjects of the prowess and the Kybersept clinical trials on endogenous anticoagulants.
    Wiedermann CJ; Keinecke HO; Jürs M; Opal SM
    Shock; 2006 Jun; 25(6):657-8. PubMed ID: 16721275
    [No Abstract]   [Full Text] [Related]  

  • 10. Antibiotic treatment in a murine model of sepsis: impact on cytokines and endotoxin release.
    Vianna RC; Gomes RN; Bozza FA; Amâncio RT; Bozza PT; David CM; Castro-Faria-Neto HC
    Shock; 2004 Feb; 21(2):115-20. PubMed ID: 14752283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of dietary fish oil on survival rate, plasma amino acid pattern, and inflammatory-related mediators in diabetic rats with sepsis.
    Chyi A; Yeh SL
    Clin Nutr; 2000 Oct; 19(5):313-8. PubMed ID: 11031068
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonin protects against oxidative organ injury in a rat model of sepsis.
    Sener G; Toklu H; Kapucu C; Ercan F; Erkanli G; Kaçmaz A; Tilki M; Yeğen BC
    Surg Today; 2005; 35(1):52-9. PubMed ID: 15622465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Only activated protein C treatment and not protein C has demonstrated an improvement in survival in severe sepsis.
    Yan SB; Dhainaut JF; Schwarz HP; Ehrlich HJ
    Crit Care Med; 2004 Feb; 32(2):618; author reply 618-9. PubMed ID: 14758203
    [No Abstract]   [Full Text] [Related]  

  • 14. Sickness behavior of rats with abdominal sepsis can be improved by antibiotic and G-CSF prophylaxis in clinic modeling randomized trials.
    Bauhofer A; Schwarting RK; Köster M; Schmitt A; Lorenz W; Pawlak CR
    Inflamm Res; 2004 Dec; 53(12):697-705. PubMed ID: 15654518
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microcirculatory disorders in sepsis and transplantation: therapy with natural coagulatory inhibitors antithrombin and activated protein C.
    Hoffmann JN; Fertmann JM; Jauch KW
    Curr Opin Crit Care; 2006 Oct; 12(5):426-30. PubMed ID: 16943720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Activated protein C in severe sepsis--joyful news].
    Møller K; Skinhøj P
    Ugeskr Laeger; 2001 Mar; 163(12):1713. PubMed ID: 11284413
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of Xuebijing injection on protein C and tumor necrosis factor-alpha mRNA in rats with sepsis].
    Li YP; Qiao YJ; Wu ZX; Qian FF; Yao YM; Yu Y; Wu Y
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Aug; 19(8):488-91. PubMed ID: 17708848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The green tea polyphenol epigallocatechin-3-gallate improves systemic hemodynamics and survival in rodent models of polymicrobial sepsis.
    Wheeler DS; Lahni PM; Hake PW; Denenberg AG; Wong HR; Snead C; Catravas JD; Zingarelli B
    Shock; 2007 Sep; 28(3):353-9. PubMed ID: 17545942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parthenolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis.
    Sheehan M; Wong HR; Hake PW; Zingarelli B
    Crit Care Med; 2003 Sep; 31(9):2263-70. PubMed ID: 14501955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inflammatory status in sepsis alters efficacy of interleukin-18 binding protein therapy.
    Remick DG; Bolgos GE; Siddiqui J
    Crit Care Med; 2003 Aug; 31(8):2096-101. PubMed ID: 12973165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.